Biotech Law 
PRESS RELEASE: BB Biotech announces structured distribution policy and specifies reasons for rejection of the proposal made by Vontobel Group – ad-hoc-news.de
… had the choice of investing in either BB Biotech AG in its form as listed investment company or the BB Biotech investment fund under Luxembourg law. In addition, there are numerous other biotech investment funds where investors can select … Continue reading
BB Biotech announces structured distribution policy and specifies reasons for rejection of the proposal made by Vontobel Group – PR Inside
The Board of Directors, with the assistance of its independent financial advisor UBS and its legal advisor Homburger, recently undertook a detailed review of all strategic options available to BB Biotech. This strategic review also included, but was not …
BB Biotech announces structured distribution policy and specifies reasons for rejection of the proposal made by Vontobel Group – Reuters
… choice of investing in either BB Biotech AG in its form as listed investment company or the BB Biotech investment fund under Luxembourg law. In addition, there are numerous other biotech investment funds where investors can select their …
BB BIOTECH AG : announces structured distribution policy and specifies reasons for rejection of the proposal made by Vontobel Group – 4-traders (press release)
The Board of Directors, with the assistance of its independent financial advisor UBS and its legal advisor Homburger, recently undertook a detailed review of all strategic options available to BB Biotech. This strategic review also included, but was not …
BB BIOTECH AG – BB Biotech announces structured distribution policy and specifies reasons for rejection of the proposal made by Vontobel Group – romandie.com
. Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Structured distribution policy to provide shareholders with an annual return of 10% through a combination of tax efficient cash …
Strategies to improve renewable energy feedstocks – EurekAlert
legal issues, and science trends. Industrial Biotechnology offers the premier forum bridging basic research and R&D with later-stage commercialization for sustainable biobased industrial and environmental applications.
Thompson Hine Recognized by LMG Life Sciences 2012 – Marketwatch
LMG Life Sciences 2012 takes a multidisciplinary approach to the legal industry servicing companies in the biotech, agritech, pharmaceutical and medical device industries. It strives to be the ultimate resource for in-house counsel identifying …
TNI BioTech, Inc., Announces the Formation of New Medical Advisory Board and Initial Board Appointments – SBWire
Members of the TNI BioTech Advisory Board are … as well as a Masters and a PhD in International Law and Economics from Johns Hopkins University. Subsequently, she worked for the US Department of Agriculture as an economist and joined … Continue reading
ShangPharma Independent Committee Appoints Chairman and Legal Counsel – Yahoo Finance
In addition, the Independent Committee has appointed O’Melveny & Myers LLP as its legal advisor. As previously announced … and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality …
MMRGlobal and VisiInc PLC Announce Major eHealth Record Solution for Australia – msnbc.com
Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 … except as required by law, does not undertake any obligation to update any forward-looking statements contained …
